StockNews.com Begins Coverage on SenesTech (NASDAQ:SNES)

Equities research analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES) in a research report issued on Saturday. The brokerage set a “sell” rating on the stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $3.50 price target on shares of SenesTech in a research note on Tuesday, May 14th.

SenesTech Stock Down 5.2 %

Shares of SNES opened at $0.70 on Friday. The stock has a 50 day simple moving average of $0.74 and a 200-day simple moving average of $1.03. The company has a debt-to-equity ratio of 0.03, a current ratio of 6.91 and a quick ratio of 5.69. SenesTech has a 1 year low of $0.52 and a 1 year high of $16.56.

SenesTech (NASDAQ:SNES) last announced its quarterly earnings data on Thursday, May 9th. The company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.02). The firm had revenue of $0.42 million for the quarter, compared to the consensus estimate of $0.43 million. SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. During the same period in the prior year, the firm posted ($15.85) earnings per share. As a group, equities research analysts expect that SenesTech will post -1.1 earnings per share for the current fiscal year.

Hedge Funds Weigh In On SenesTech

An institutional investor recently bought a new position in SenesTech stock. McAdam LLC acquired a new position in shares of SenesTech, Inc. (NASDAQ:SNES) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned approximately 1.25% of SenesTech as of its most recent SEC filing. Hedge funds and other institutional investors own 5.19% of the company’s stock.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.